191 related articles for article (PubMed ID: 17031043)
1. Chemoenzymatic synthesis of a MUC1 glycopeptide carrying non-natural sialyl TF-beta O-glycan.
Tanaka E; Nakahara Y; Kuroda Y; Takano Y; Kojima N; Hojo H; Nakahara Y
Biosci Biotechnol Biochem; 2006 Oct; 70(10):2515-22. PubMed ID: 17031043
[TBL] [Abstract][Full Text] [Related]
2. Solid-phase synthesis of core 8 O-glycan-linked MUC5AC glycopeptide.
Maemura M; Ohgaki A; Nakahara Y; Hojo H; Nakahara Y
Biosci Biotechnol Biochem; 2005 Aug; 69(8):1575-83. PubMed ID: 16116288
[TBL] [Abstract][Full Text] [Related]
3. Parallel solid-phase synthesis of mucin-like glycopeptides.
Liu M; Barany G; Live D
Carbohydr Res; 2005 Sep; 340(13):2111-22. PubMed ID: 16026772
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
Hanisch FG; Stadie T; Bosslet K
Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
[TBL] [Abstract][Full Text] [Related]
5. Chemoenzymatic synthesis of sialylated glycopeptides derived from mucins and T-cell stimulating peptides.
George SK; Schwientek T; Holm B; Reis CA; Clausen H; Kihlberg J
J Am Chem Soc; 2001 Nov; 123(45):11117-25. PubMed ID: 11697954
[TBL] [Abstract][Full Text] [Related]
6. A unified strategy for the synthesis of mucin cores 1-4 saccharides and the assembled multivalent glycopeptides.
Pett C; Schorlemer M; Westerlind U
Chemistry; 2013 Dec; 19(50):17001-10. PubMed ID: 24307362
[TBL] [Abstract][Full Text] [Related]
7. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
[TBL] [Abstract][Full Text] [Related]
8. Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides.
Rodriguez MC; Yegorova S; Pitteloud JP; Chavaroche AE; André S; Ardá A; Minond D; Jiménez-Barbero J; Gabius HJ; Cudic M
Biochemistry; 2015 Jul; 54(29):4462-74. PubMed ID: 26129647
[TBL] [Abstract][Full Text] [Related]
9. Synthetic glycopeptides for the development of tumour-selective vaccines.
Kunz H
J Pept Sci; 2003 Sep; 9(9):563-73. PubMed ID: 14552419
[TBL] [Abstract][Full Text] [Related]
10. Efficient synthesis of a sialyl T-antigen-linked glycopeptide by the chemoenzymatic method.
Ajisaka K; Miyasato M
Biosci Biotechnol Biochem; 2000 Aug; 64(8):1743-6. PubMed ID: 10993167
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4.
Dziadek S; Brocke C; Kunz H
Chemistry; 2004 Sep; 10(17):4150-62. PubMed ID: 15352098
[TBL] [Abstract][Full Text] [Related]
12. Multiple column synthesis of a library of T-cell stimulating Tn-antigenic glycopeptide analogues for the molecular characterization of T-cell-glycan specificity.
Frische K; Meldal M; Werdelin O; Mouritsen S; Jensen T; Galli-Stampino L; Bock K
J Pept Sci; 1996; 2(4):212-22. PubMed ID: 9231328
[TBL] [Abstract][Full Text] [Related]
13. A concise methodology for the stereoselective synthesis of O-glycosylated amino acid building blocks: complete 1H NMR assignments and their application in solid-phase glycopeptide synthesis.
Satyanarayana J; Gururaja TL; Naganagowda GA; Ramasubbu N; Levine MJ
J Pept Res; 1998 Sep; 52(3):165-79. PubMed ID: 9774229
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of the glycosyl amino acids N alpha-Fmoc-Ser[Ac4-beta-D-Galp-(1-->3)-Ac2-alpha-D-GalN3p]-OPfp and N alpha-Fmoc-Thr[Ac4-beta-D-Galp-(1-->3)-Ac2-alpha-D-GalN3p]-OPfp and the application in the solid-phase peptide synthesis of multiply glycosylated mucin peptides with Tn and T antigenic structures.
Paulsen H; Peters S; Bielfeldt T; Meldal M; Bock K
Carbohydr Res; 1995 Mar; 268(1):17-34. PubMed ID: 7736464
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of glycans to beta-elimination in Fmoc-based O-glycopeptide synthesis.
Meldal M; Bielfeldt T; Peters S; Jensen KJ; Paulsen H; Bock K
Int J Pept Protein Res; 1994 Jun; 43(6):529-36. PubMed ID: 7928083
[TBL] [Abstract][Full Text] [Related]
16. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
17. Efficient substitution reaction from cysteine to the serine residue of glycosylated polypeptide: repetitive peptide segment ligation strategy and the synthesis of glycosylated tetracontapeptide having acid labile sialyl-T(N) antigens.
Okamoto R; Souma S; Kajihara Y
J Org Chem; 2009 Mar; 74(6):2494-501. PubMed ID: 19236026
[TBL] [Abstract][Full Text] [Related]
18. Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.
Revoredo L; Wang S; Bennett EP; Clausen H; Moremen KW; Jarvis DL; Ten Hagen KG; Tabak LA; Gerken TA
Glycobiology; 2016 Apr; 26(4):360-76. PubMed ID: 26610890
[TBL] [Abstract][Full Text] [Related]
19. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
[TBL] [Abstract][Full Text] [Related]
20. Preparation of glycosylated amino acids suitable for Fmoc solid-phase assembly.
Cudic M; Burstein GD
Methods Mol Biol; 2008; 494():187-208. PubMed ID: 18726575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
